Your browser doesn't support javascript.
loading
Serum metabolomics can predict the outcome of first systematic transrectal prostate biopsy in patients with PSA <10 ng/ml.
Andras, Iulia; Crisan, Nicolae; Vesa, Stefan; Rahota, Razvan; Romanciuc, Florina; Lazar, Andrei; Socaciu, Carmen; Matei, Deliu-Victor; de Cobelli, Ottavio; Bocsan, Ioan-Stelian; Coman, Radu-Tudor.
Affiliation
  • Andras I; Department of Urology, Iuliu Hatieganu University of Medicine & Pharmacy, Cluj-Napoca, Romania.
  • Crisan N; Department of Urology, Clinical Municipal Hospital, Cluj-Napoca, Romania.
  • Vesa S; Department of Urology, Iuliu Hatieganu University of Medicine & Pharmacy, Cluj-Napoca, Romania.
  • Rahota R; Department of Urology, Clinical Municipal Hospital, Cluj-Napoca, Romania.
  • Romanciuc F; Department of Pharmacology, Toxicology & Clinical Pharmacology, Iuliu Hatieganu University of Medicine & Pharmacy, Cluj-Napoca, Romania.
  • Lazar A; Department of Urology, Clinical Municipal Hospital, Cluj-Napoca, Romania.
  • Socaciu C; Center for Applied Biotechnology BIODIATECH, SC Proplanta, Cluj-Napoca, Romania.
  • Matei DV; Center for Applied Biotechnology BIODIATECH, SC Proplanta, Cluj-Napoca, Romania.
  • de Cobelli O; Center for Applied Biotechnology BIODIATECH, SC Proplanta, Cluj-Napoca, Romania.
  • Bocsan IS; Department of Urology, European Institute of Oncology, Milan, Italy.
  • Coman RT; Department of Urology, European Institute of Oncology, Milan, Italy.
Future Oncol ; 13(20): 1793-1800, 2017 Aug.
Article de En | MEDLINE | ID: mdl-28776421

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / Antigène spécifique de la prostate / Métabolome / Métabolomique Type d'étude: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Humans / Male / Middle aged Langue: En Journal: Future Oncol Année: 2017 Type de document: Article Pays d'affiliation: Roumanie Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / Antigène spécifique de la prostate / Métabolome / Métabolomique Type d'étude: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Humans / Male / Middle aged Langue: En Journal: Future Oncol Année: 2017 Type de document: Article Pays d'affiliation: Roumanie Pays de publication: Royaume-Uni